Takara Bio Inc. (OTCMKTS:TKBIF) Short Interest Update

Takara Bio Inc. (OTCMKTS:TKBIF) saw a large growth in short interest in the month of January. As of January 15th, there was short interest totalling 17,400 shares, a growth of 21.7% from the December 31st total of 14,300 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

Takara Bio Stock Performance

TKBIF opened at $23.20 on Monday. The business has a fifty day moving average of $23.20 and a 200 day moving average of $23.20. Takara Bio has a 52-week low of $23.20 and a 52-week high of $23.20.

About Takara Bio

Takara Bio Inc, together with its subsidiaries, engages in bioindustry, contract development and manufacturing organization (CDMO), and gene therapy businesses in Japan, China, rest of Asia, the United States, Europe, and internationally. The company sells reagents and instruments, including genetic research reagents and testing kits; products related to coronavirus testing comprising in vitro diagnostics that detect viruses; analytical reagents; single-cell analysis systems; gene expression research reagents; fluorescent proteins series; genome-editing research reagents; iPS cell research reagents; and products for stem cell culturing and induction of differentiation under the TaKaRa, Clontech, and Cellartis brand names.